Exact Sciences Corporation
EXAS | NASDAQ
$104.91
$0.00 (0.00%)
Nov 2, 2026, 12:02 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -92.33 | -10.05 | -65.47 | -13.99 | -22.36 | -24.31 |
PEG Ratio | 1.15 | -0.03 | 0.96 | -8.11 | 0.62 | -0.10 |
PS Ratio | 5.90 | 3.75 | 5.33 | 4.19 | 7.55 | 13.43 |
PB Ratio | 7.98 | 4.31 | 4.24 | 2.87 | 3.94 | 8.96 |
P/FCF Ratio | 53.71 | 138.84 | 417.40 | -19.93 | -56.03 | 277.61 |
P/OCF Ratio | 38.99 | 49.16 | 85.36 | -39.06 | -130.44 | 146.72 |
OCF/S Ratio | 15.14 | 7.63 | 6.25 | -10.73 | -5.79 | 9.15 |
Debt / Equity Ratio | 1.05 | 1.15 | 0.81 | 0.80 | 0.70 | 1.04 |
Quick Ratio | 2.17 | 1.92 | 2.07 | 2.09 | 2.56 | 3.33 |
Current Ratio | 2.43 | 2.15 | 2.32 | 2.38 | 2.76 | 3.47 |
Asset Turnover | 0.55 | 0.47 | 0.39 | 0.33 | 0.26 | 0.30 |
Interest Coverage | -3.01 | -32.80 | -8.80 | -42.68 | -66.44 | -44.84 |
Return on Equity | -8.66% | -42.83% | -6.49% | -20.49% | -17.58% | -36.84% |
Return on Assets | -3.55% | -17.36% | -3.15% | -10.01% | -8.91% | -16.72% |
Return on Invested Capital | -1.88% | -19.03% | -3.56% | -10.01% | -9.78% | -16.52% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 69.69% | 69.55% | 70.49% | 68.27% | 74.04% | 76.24% |
Net Profit Margin | -6.40% | -37.29% | -8.17% | -29.91% | -33.71% | -55.22% |
Pretax Profit Margin | -6.28% | -37.56% | -8.07% | -30.35% | -47.68% | -55.59% |
Operating Profit Margin | -3.05% | -38.01% | -8.60% | -28.48% | -48.42% | -51.48% |
FCF Margin | 10.99% | 2.70% | 1.28% | -21.02% | -13.47% | 4.84% |
EBITDA Margin | 1.56% | -28.61% | 1.17% | -20.20% | -36.74% | -43.84% |
Add to Watchlist
Select watchlists to add or remove EXAS